Skip to main content
Tech.euFundingExplorerBeta

Blueprint Genetics

Uses Next Generation Sequencing (NGS) to perform diagnostics on genetic diseases

Helsinki, FinlandFounded 2012www.blueprintgenetics.com ↗
Healthtech
← All companies
Total raised
€21M
€21,055,454
Funding rounds
3
Investors
6
distinct backers
Active since
2014-07
latest 2017-08

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood18
base rate 44% for Series A
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
  • ▲ 3 rounds raised
  • ▲ 14y since founding

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds
DateStageAmountInvestors
2017-08-03Series A€14MCreathor Venture,Inventure Oy,MedTech Innovation Partners,Pontos Group,Stanford UniversityView deal →
2014-09-01Other€3.5M—View deal →
2014-08-01Seed€3.5MInVenture PartnersView deal →

Investors

6
Creathor VentureInventure OyInVenture PartnersMedTech Innovation PartnersPontos GroupStanford University

Related news

Similar companies

same sector or country